期刊文献+

HPLC法测定1-氟萘中工艺杂质和遗传毒性杂质含量

Determination of process-related impurities and genotoxic impurities in 1-fluoronaphthalene by HPLC
下载PDF
导出
摘要 建立了1-氟萘中的2种工艺杂质和1种遗传毒性杂质含量检测的HPLC方法。采用Phenomenex Gemini色谱柱(C18250×4.6mm,5µm);流动相为10mM碳酸氢钠+6mM三乙胺∶乙腈=55∶45,等度洗脱,采集时间为主峰的2倍保留时间;柱温为40℃;检测波长为220nm;流速为1.0mL/min;进样量为20μL。采用加校正因子的主成分自身对照法对各杂质进行计算,各杂质分离度良好,定量限为0.005~0.008μg/ml,线性关系良好,精密度和高中低三浓度准确度符合要求。实验结果表明该方法专属性强、灵敏度高、操作简便、重复性好、结果准确可靠,可用于1-氟萘中杂质控制。 To establish an HPLC method for the detection of two known impurities and one genotoxic impurities contents in 1-fluoronaphthalene.The chromatographic column was Phenomenex Gemini C18250×4.6 mm,5μm;the mobile phase was 10 mM sodium bicarbonate+6 mM triethylamine:acetonitrile=55:45,isometric elution,and the collection time was twice the retention time of the main peak;the column temperature was 40℃;the detection wavelength was 220 nm;the flow rate was 1.0 mL/min;the injection volume was 20μL.The main component self-comparison with correction factor was used to calculate each impurity,and each impurity could be well separated,the LOQ was 0.005-0.008μg/ml,and the linear relationship is good,and the precision and accuracy of high,medium and low three concentrations meet the requirements.The results show the method has strong specificity,high sensitivity and easy operation,good repeatability,accurate and reliable results,can be used for impurity control of 1-fluoronaphthalene.
作者 唐莲 杨仁明 Tang Lian;Yang Renming(Chengdu DIAO Pharmaceutical Group Co.,Ltd.,Chengdu,Sichuan 610041,China;Sichuan Aupone GOOD Pharmaceutical Co.,Ltd.,Chengdu,Sichuan 610097,China)
出处 《化工与医药工程》 CAS 2024年第1期32-38,共7页 Chemical and Pharmaceutical Engineering
关键词 HPLC 1-氟萘 工艺杂质 遗传毒性杂质 含量 HPLC 1-fluoronaphthalene process-related impurity genotoxic impurity determination
  • 相关文献

参考文献5

二级参考文献35

  • 1高丽梅,朱凤昌,宋丹青.盐酸度洛西汀的合成[J].中国新药杂志,2005,14(1):74-76. 被引量:10
  • 2Li ZS, Jinan L, Yang Z. Comparative effectiveness in pain-related out-comes and health care utilizations between veterans with major depressivedisorder treated with duloxetine and other antidepressants : A retrospec-tive propensity score-matched comparison [ J] . Pain Practi,2012,12:374-384.
  • 3Lai CH,Wu YT. Frontal regional homogeneity increased and temporal re-gional homogeneity decreased after remission of first-episode drug-na. vemajor depressive disorder with panic disorder patients under duloxetinetherapy for 6 weeks[ J] - J Affect Disord,2012,136:453 -458.
  • 4Oakes TM, Myers AL, Marangell LB, et al. Assessment of depressivesymptoms and functional outcomes in patients with major depressive dis-order treated with duloxetine versus placebo : primary outcomes from twotrials conducted under the same protocol[ J]. Human Psychopharmacol,2012,27:47-56.
  • 5Ulu S^Elmali F. Validated spectrophotometric method for the deteimina-tion,spectroscopic characterization and thermal stmctural {malysis of du-loxetine with 1, 2-naphthoquinone-4-sulphonate [ J]. Optics Spectr,2012,112:431 -437.
  • 6Reddy P,Sreeramulu J,Naidu P,et al. Stability Indicating Fast LC forthe Simultaneous Estimation of Intermediates and Degradants (rf Duloxe-tine Hydrochloride[ J]. Chromatographia ,2010,71:95 - 100.
  • 7Zhao RK,Cheng G,Tang J,et al. Pharmacokinetics of duloxetine hydro-chloride enteric-coated tablets in healthy Chinese volunte.B : A random-ized ,open-label, single-and multiple . dose study [ J]. Clin Therapeu-tics ,2009,31 :1022 -1036.
  • 8Musenga A,Amore M, Mandrioli H. Determination of duloxetine in hu-man plasma by capillary ^ectrophoresis with laser-induced fluorescencedetection[ J]. J Chromatc^r B Analyt Technol Biomed life Sci,2009,877:1126-1132.
  • 9崔德斌,李立威.高效液相色谱法测定1-氟萘中2-氟萘的含量[J].医药导报,2007,26(7):812-813. 被引量:2
  • 10Li J, Yuan H, Bai Y, et al. Dapoxetine for premature eja- culation: an updated meta-analysis of randomized controlled trials [J]. ClinTher, 2014, 36 (12) : 2003-2014.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部